Company Encyclopedia
View More
name
KANGHUA HEALTH
03689.HK
Guangdong Kanghua Healthcare Group Co., Ltd. primarily operates private hospitals in the People’s Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, Haemodialysis Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services.
34.20 B
03689.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care FacilitiesIndustry
Industry Ranking12/18
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE5.36%C
    • Profit Margin3.73%C
    • Gross Margin16.15%D
  • Growth ScoreC
    • Revenue YoY0.83%C
    • Net Profit YoY50.67%B
    • Total Assets YoY6.94%B
    • Net Assets YoY4.54%C
  • Cash ScoreB
    • Cash Flow Margin2682.51%A
    • OCF YoY0.83%C
  • Operating ScoreB
    • Turnover0.75B
  • Debt ScoreC
    • Gearing Ratio47.41%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    KANGHUA HEALTH appoints Jiang Xiwen as a non-executive director

    According to the Zhitong Finance APP, KANGHUA HEALTH announced that Mr. Lv Yubo has submitted his resignation as a non-executive director, and Mr. Jiang Xiwen has been appointed as a non-executive director, effective from October 17, 2025

    Zhitong·
    HK
    03689
    +15.00%
    Zhitong·
    HK
    03689
    +15.00%

    KANGHUA HEALTH released its interim results, with a profit attributable to shareholders of HKD 41.642 million, turning a profit compared to the same period last year

    According to the Zhitong Finance APP, KANGHUA HEALTH announced that the group achieved revenue of RMB 982 million during the period, a year-on-year decrease of 0.3%; the profit attributable to the company's owners was RMB 41.642 million, turning from a loss to a profit year-on-year; the basic earnings per share were 12.5 cents

    Zhitong·
    HK
    03689
    +15.00%
    Zhitong·
    HK
    03689
    +15.00%

    KANGHUA HEALTH issues a profit warning, expecting a mid-term profit of HKD 32 million to 33 million, turning a loss into a profit year-on-year

    KANGHUA HEALTH expects to achieve a profit of HKD 32 million to 33 million within the six months ending June 30, 2025, turning a loss into a profit, mainly due to the sale of 55% equity in Kangxin Hospital, with expected revenue of approximately HKD 19.5 million. After the sale, the losses of Kangxin Hospital will no longer be included in the group's financial performance, with an expected share of losses of approximately HKD 18.4 million, resulting in a positive impact on the group's financial performance

    Zhitong·
    HK
    03689
    +15.00%
    Zhitong·
    HK
    03689
    +15.00%

    "Profit Alert" KANGHUA HEALTH expects to turn a profit of up to 33 million RMB in the interim

    KANGHUA HEALTH expects to achieve a profit of RMB 32 million to RMB 33 million by mid-2025, a significant improvement compared to a loss of approximately RMB 24.7 million by mid-2024. This profit is mainly attributed to the group's sale of a 55% stake in Kangxin Hospital, which is expected to generate a disposal gain of approximately RMB 19.5 million, significantly improving financial performance

    AASTOCKS·
    HK
    03689
    +15.00%
    AASTOCKS·
    HK
    03689
    +15.00%

    Investment Log for Hong Kong Stocks | June 23

    The Hong Kong stock investment log for June 23, 2025, includes new stock activities, earnings announcement dates, shareholder meeting dates, and dividend distribution information. New stock activities include TaiDe Pharmaceutical and UNISOUND, which are currently in the offering process, while TRANSTHERA-B has already been listed. Earnings announcement dates involve MANSHING GLOBAL and other companies, while shareholder meetings include MCC and others. Regarding dividend distribution, MAX SIGHT GROUP and KANGHUA HEALTH have relevant arrangements

    Zhitong·
    HK
    02617
    -1.03%
    HK
    09678
    +6.00%
    HK
    08483
    -1.52%
    Zhitong·
    HK
    02617
    -1.03%
    HK
    09678
    +6.00%
    HK
    08483
    -1.52%
    © 2025 Longbridge｜Disclaimer